BiondVax Pharmaceuticals Ltd. (BVXV) Stock Faltering in Aftermarket, Here’s Why
BiondVax Pharmaceuticals Ltd. (BVXV), a biopharmaceutical company, closed Friday’s regular trading session at $1.68 after gaining an increase of 1.20 percentage points. In the aftermarket trading session, however, BVXV stock has shown an abysmal performance. The stock was trading at $1.56 after plunging 7.14% at the last check. The poor performance could be attributed to […]
